The biological significance and clinical applications of exosomes in ovarian cancer

Gynecologic Oncology

Volumn 142, Issue 1, 2016, Pages 199-205

  Dorayappan, Kalpana Deepa Priya ^a   Wallbillich, John J ^a   Cohn, David E ^a   Selvendiran, Karuppaiyah ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Bio marker; Exosomes; Hypoxia; micro RNA; Ovarian cancer

Indexed keywords

ALDEHYDE REDUCTASE; ALIX PROTEIN; BETA CATENIN; BIOLOGICAL MARKER; CASEIN KINASE II; CAVEOLIN 1; CD37 ANTIGEN; CD53 ANTIGEN; CD63 ANTIGEN; CD81 ANTIGEN; CD82 ANTIGEN; CLAUDIN 4; EPITHELIAL CELL ADHESION MOLECULE; GELATINASE A; HEAT SHOCK COGNATE PROTEIN 70; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 84; HEAT SHOCK PROTEIN 90; HEPATOMA DERIVED GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; LIPOCORTIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; MICRORNA; PEROXIREDOXIN; RNA INDUCED SILENCING COMPLEX; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; TUMOR MARKER;

3' UNTRANSLATED REGION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; DRUG DELIVERY SYSTEM; EPITHELIAL MESENCHYMAL TRANSITION; EXOSOME; FATTY ACID SYNTHESIS; METASTASIS; MORTALITY RATE; OVARY CANCER; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; DRUG RESISTANCE; FEMALE; GENETICS; HUMAN; OVARIAN NEOPLASMS; PATHOLOGY;

ANIMALS; BIOMARKERS, TUMOR; DRUG RESISTANCE, NEOPLASM; EXOSOMES; FEMALE; HUMANS; MICRORNAS; NEOPLASM METASTASIS; OVARIAN NEOPLASMS;

EID: 84962675054     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2016.03.036     Document Type: Review

References (70)

1. W. Nickel Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells Traffic 6 2005 607 614
2. R.L. Giuntoli II, T.J. Webb, A. Zoso, O. Rogers, T.P. Diaz-Montes, R.E. Bristow, and et al. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity Anticancer Res. 29 2009 2875 2884
3. M. Szajnik, M. Derbis, M. Lach, P. Patalas, M. Michalak, H. Drzewiecka, and et al. Exosomes in plasma of patients with ovarian carcinoma: potential biomarkers of tumor progression and response to therapy Gynecol. Obstet. Suppl. 4 2013 3
4. S. Runz, S. Keller, C. Rupp, A. Stoeck, Y. Issa, D. Koensgen, and et al. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM Gynecol. Oncol. 107 2007 563 571
5. S. Dutta, C. Warshall, C. Bandyopadhyay, D. Dutta, and B. Chandran Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells PLoS One 9 2014 e97580
6. A. Hoshino, B. Costa-Silva, T.L. Shen, G. Rodrigues, A. Hashimoto, M. Tesic Mark, and et al. Tumour exosome integrins determine organotropic metastasis Nature 527 2015 329 335
7. M.M. Lv, X.Y. Zhu, W.X. Chen, S.L. Zhong, Q. Hu, T.F. Ma, and et al. Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein Tumour Biol. 35 2014 10773 10779
8. D.D. Taylor, H.D. Homesley, and G.J. Doellgast "Membrane-associated" immunoglobulins in cyst and ascites fluids of ovarian cancer patients Am. J. Reprod. Immunol. 3 1983 7 11
9. C. Escrevente, S. Keller, P. Altevogt, and J. Costa Interaction and uptake of exosomes by ovarian cancer cells BMC Cancer 11 2011 108
10. J.L. Welton, S. Khanna, P.J. Giles, P. Brennan, I.A. Brewis, J. Staffurth, and et al. Proteomics analysis of bladder cancer exosomes Mol. Cell. Proteomics 9 2010 1324 1338
11. R. Valenti, V. Huber, M. Iero, P. Filipazzi, G. Parmiani, and L. Rivoltini Tumor-released microvesicles as vehicles of immunosuppression Cancer Res. 67 2007 2912 2915
12. T.L. Whiteside Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system? Br. J. Cancer 92 2005 209 211
13. D.D. Taylor, and C. Gercel-Taylor Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects Br. J. Cancer 92 2005 305 311
14. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA Cancer J. Clin. 65 2015 5 29
15. SEER stat fact sheets Ovary Cancer 2015
16. J.A. Tickner, A.J. Urquhart, S.A. Stephenson, D.J. Richard, and K.J. O'Byrne Functions and therapeutic roles of exosomes in cancer Front Oncol. 4 2014 127
17. V.O. Shender, M.S. Pavlyukov, R.H. Ziganshin, G.P. Arapidi, S.I. Kovalchuk, N.A. Anikanov, and et al. Proteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication Mol. Cell. Proteomics 13 2014 3558 3571
18. V.A. Enriquez, E.R. Cleys, J.C. Da Silveira, M.A. Spillman, Q.A. Winger, and G.J. Bouma High LIN28A expressing ovarian cancer cells secrete exosomes that induce invasion and migration in HEK293 cells Biomed. Res. Int. 2015 2015 701390
19. J. Yin, X. Yan, X. Yao, Y. Zhang, Y. Shan, N. Mao, and et al. Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients J. Cell. Mol. Med. 16 2012 337 348
20. K. Al-Nedawi, B. Meehan, and J. Rak Microvesicles: messengers and mediators of tumor progression Cell Cycle 8 2009 2014 2018
21. S. Khan, J.M. Jutzy, J.R. Aspe, D.W. McGregor, J.W. Neidigh, and N.R. Wall Survivin is released from cancer cells via exosomes Apoptosis 16 2011 1 12
22. D.D. Taylor, and C. Gercel-Taylor MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer Gynecol. Oncol. 110 2008 13 21
23. E.S. Ratner, D. Tuck, C. Richter, S. Nallur, R.M. Patel, V. Schultz, and et al. MicroRNA signatures differentiate uterine cancer tumor subtypes Gynecol. Oncol. 118 2010 251 257
24. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
25. E. Maniataki, and Z. Mourelatos A human, ATP-independent, RISC assembly machine fueled by pre-miRNA Genes Dev. 19 2005 2979 2990
26. Q.J. Luo, M.P. Samanta, F. Koksal, J. Janda, D.W. Galbraith, C.R. Richardson, and et al. Evidence for antisense transcription associated with microRNA target mRNAs in Arabidopsis PLoS Genet. 5 2009 e1000457
27. J.T. Mendell, and E.N. Olson MicroRNAs in stress signaling and human disease Cell 148 2012 1172 1187
28. J. Gilabert-Estelles, A. Braza-Boils, L.A. Ramon, E. Zorio, P. Medina, F. Espana, and et al. Role of microRNAs in gynecological pathology Curr. Med. Chem. 19 2012 2406 2413
29. C. Villarroya-Beltri, C. Gutierrez-Vazquez, F. Sanchez-Madrid, and M. Mittelbrunn Analysis of microRNA and protein transfer by exosomes during an immune synapse Methods Mol. Biol. 1024 2013 41 51
30. M.L. Squadrito, C. Baer, F. Burdet, C. Maderna, G.D. Gilfillan, R. Lyle, and et al. Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells Cell Rep. 8 2014 1432 1446
31. B. Liang, P. Peng, S. Chen, L. Li, M. Zhang, D. Cao, and et al. Characterization and proteomic analysis of ovarian cancer-derived exosomes J. Proteome 80 2013 171 182
32. M. Kobayashi, C. Salomon, J. Tapia, S.E. Illanes, M.D. Mitchell, and G.E. Rice Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200 J. Transl. Med. 12 2014 4
33. S.D. Li, J.R. Zhang, Y.Q. Wang, and X.P. Wan The role of microRNAs in ovarian cancer initiation and progression J. Cell. Mol. Med. 14 2010 2240 2249
34. A. Sorrentino, C.G. Liu, A. Addario, C. Peschle, G. Scambia, and C. Ferlini Role of microRNAs in drug-resistant ovarian cancer cells Gynecol. Oncol. 111 2008 478 486
35. R. Cappellesso, A. Tinazzi, T. Giurici, F. Simonato, V. Guzzardo, L. Ventura, and et al. Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions Cancer Cytopathol. 122 2014 685 693
36. O. Vaksman, C. Trope, B. Davidson, and R. Reich Exosome-derived miRNAs and ovarian carcinoma progression Carcinogenesis 35 2014 2113 2120
37. H.W. King, M.Z. Michael, and J.M. Gleadle Hypoxic enhancement of exosome release by breast cancer cells BMC Cancer 12 2012 421
38. A.S. Azmi, B. Bao, and F.H. Sarkar Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review Cancer Metastasis Rev. 32 2013 623 642
39. S. Keller, A.K. Konig, F. Marme, S. Runz, S. Wolterink, D. Koensgen, and et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes Cancer Lett. 278 2009 73 81
40. H. Peinado, S. Lavotshkin, and D. Lyden The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts Semin. Cancer Biol. 21 2011 139 146
41. T. Jung, D. Castellana, P. Klingbeil, I. Cuesta Hernandez, M. Vitacolonna, D.J. Orlicky, and et al. CD44v6 dependence of premetastatic niche preparation by exosomes Neoplasia 11 2009 1093 1105
42. S. Pradeep, S.W. Kim, S.Y. Wu, M. Nishimura, P. Chaluvally-Raghavan, T. Miyake, and et al. Hematogenous metastasis of ovarian cancer: rethinking mode of spread Cancer Cell 26 2014 77 91
43. A. Ramteke, H. Ting, C. Agarwal, S. Mateen, R. Somasagara, A. Hussain, and et al. Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules Mol. Carcinog. 54 2015 554 565
44. F. Felicetti, I. Parolini, L. Bottero, K. Fecchi, M.C. Errico, C. Raggi, and et al. Caveolin-1 tumor-promoting role in human melanoma Int. J. Cancer 125 2009 1514 1522
45. J.C. Gross, V. Chaudhary, K. Bartscherer, and M. Boutros Active Wnt proteins are secreted on exosomes Nat. Cell Biol. 14 2012 1036 1045
46. G.A. McCann, S. Naidu, K.S. Rath, H.K. Bid, B.J. Tierney, A. Suarez, and et al. Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor Oncoscience 1 2014 216 228
47. L. Rauschenberger, D. Staar, K. Thom, C. Scharf, S. Venz, G. Homuth, and et al. Exosomal particles secreted by prostate cancer cells are potent mRNA and protein vehicles for the interference of tumor and tumor environment Prostate 2015
48. M.K. Tang, and A.S. Wong Exosomes: emerging biomarkers and targets for ovarian cancer Cancer Lett. 367 2015 26 33
49. W. Zhang, P. Peng, Y. Kuang, J. Yang, D. Cao, Y. You, and et al. Characterization of exosomes derived from ovarian cancer cells and normal ovarian epithelial cells by nanoparticle tracking analysis Tumour Biol. 2015
50. M. Li, A.J. Rai, G. Joel DeCastro, E. Zeringer, T. Barta, S. Magdaleno, and et al. An optimized procedure for exosome isolation and analysis using serum samples: application to cancer biomarker discovery Methods 87 2015 26 30
51. M. Fabbri, A. Paone, F. Calore, R. Galli, E. Gaudio, R. Santhanam, and et al. MicroRNAs bind to toll-like receptors to induce prometastatic inflammatory response Proc. Natl. Acad. Sci. U. S. A. 109 2012 E2110 E2116
52. N. Karachaliou, C. Mayo-de-Las-Casas, M.A. Molina-Vila, and R. Rosell Real-time liquid biopsies become a reality in cancer treatment Ann. Transl. Med. 3 2015 36
53. J. Li, C.A. Sherman-Baust, M. Tsai-Turton, R.E. Bristow, R.B. Roden, and P.J. Morin Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer BMC Cancer 9 2009 244
54. R. Safaei, B.J. Larson, T.C. Cheng, M.A. Gibson, S. Otani, W. Naerdemann, and et al. Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells Mol. Cancer Ther. 4 2005 1595 1604
55. R.C. Pink, P. Samuel, D. Massa, D.P. Caley, S.A. Brooks, and D.R. Carter The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells Gynecol. Oncol. 137 2015 143 151
56. K. Weiner-Gorzel, E. Dempsey, M. Milewska, A. McGoldrick, V. Toh, A. Walsh, and et al. Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells Cancer med. 4 2015 745 758
57. V. Ciravolo, V. Huber, G.C. Ghedini, E. Venturelli, F. Bianchi, M. Campiglio, and et al. Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy J. Cell. Physiol. 227 2012 658 667
58. K. Trajkovic, C. Hsu, S. Chiantia, L. Rajendran, D. Wenzel, F. Wieland, and et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes Science 319 2008 1244 1247
59. G. Pelosi, A. Fabbri, F. Bianchi, P. Maisonneuve, G. Rossi, M. Barbareschi, and et al. DeltaNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach J. Thorac. Oncol. 7 2012 281 290
60. F. Chalmin, S. Ladoire, G. Mignot, J. Vincent, M. Bruchard, J.P. Remy-Martin, and et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells J. Clin. Invest. 120 2010 457 471
61. M. Ostrowski, N.B. Carmo, S. Krumeich, I. Fanget, G. Raposo, A. Savina, and et al. Rab27a and Rab27b control different steps of the exosome secretion pathway Nat. Cell Biol. 12 19-30; sup 2010 1 13
62. A.M. Marleau, C.S. Chen, J.A. Joyce, and R.H. Tullis Exosome removal as a therapeutic adjuvant in cancer J. Transl. Med. 10 2012 134
63. B. Escudier, T. Dorval, N. Chaput, F. Andre, M.P. Caby, S. Novault, and et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial J. Transl. Med. 3 2005 10
64. M.A. Morse, J. Garst, T. Osada, S. Khan, A. Hobeika, T.M. Clay, and et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer J. Transl. Med. 3 2005 9
65. S. Dai, D. Wei, Z. Wu, X. Zhou, X. Wei, H. Huang, and et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer Mol. Ther. 16 2008 782 790
66. Z.C. Hartman, J. Wei, O.K. Glass, H. Guo, G. Lei, X.Y. Yang, and et al. Increasing vaccine potency through exosome antigen targeting Vaccine 29 2011 9361 9367
67. D. Sun, X. Zhuang, X. Xiang, Y. Liu, S. Zhang, C. Liu, and et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes Mol. Ther. 18 2010 1606 1614
68. Y. Tian, X. Jiang, X. Chen, Z. Shao, and W. Yang Doxorubicin-loaded magnetic silk fibroin nanoparticles for targeted therapy of multidrug-resistant cancer Adv. Mater. 26 2014 7393 7398
69. K.B. Johnsen, J.M. Gudbergsson, M.N. Skov, L. Pilgaard, T. Moos, and M. Duroux A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy Biochim. Biophys. Acta 2014 1846 75 87
70. S.A. Kooijmans, P. Vader, S.M. van Dommelen, W.W. van Solinge, and R.M. Schiffelers Exosome mimetics: a novel class of drug delivery systems Int. J. Nanomedicine 7 2012 1525 1541